Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: April 17, 2008
Last updated: January 26, 2012
Last verified: January 2012